Analyst Ratings For AmerisourceBergen Corp. (NYSE:ABC)
Today, Royal Bank of Canada set its price target on AmerisourceBergen Corp. (NYSE:ABC) to $87.00 per share.
There are 9 Buy Ratings, 6 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on AmerisourceBergen Corp. (NYSE:ABC) is Buy with a consensus target price of $100.7143 per share, a potential 14.68% upside.
Some recent analyst ratings include
- 9/19/2018-AmerisourceBergen Corp. (NYSE:ABC) had its Neutral rating reiterated by Mizuho
- 8/3/2018-AmerisourceBergen Corp. (NYSE:ABC) had its Hold rating reiterated by Robert W. Baird with a $89.00 price target
- 2/27/2018-AmerisourceBergen Corp. (NYSE:ABC) had its Buy rating reiterated by Cowen with a $108.00 price target
- On 11/28/2018 Lazarus Krikorian, Insider, sold 20,276 with an average share price of $90.37 per share and the total transaction amounting to $1,832,342.12.
- On 11/21/2018 Gina Clark, EVP, sold 29,549 with an average share price of $88.33 per share and the total transaction amounting to $2,610,063.17.
- On 11/20/2018 Kathy H Gaddes, Insider, sold 2,652 with an average share price of $90.54 per share and the total transaction amounting to $240,112.08.
- On 11/15/2018 John G Chou, Insider, sold 6,974 with an average share price of $88.51 per share and the total transaction amounting to $617,268.74.
- On 11/1/2018 Steven H Collis, Chairman, sold 21,350 with an average share price of $90.92 per share and the total transaction amounting to $1,941,142.00.
- On 10/22/2018 Kathy H Gaddes, EVP, sold 2,652 with an average share price of $92.96 per share and the total transaction amounting to $246,529.92.
- On 10/15/2018 John G Chou, EVP, sold 6,974 with an average share price of $88.07 per share and the total transaction amounting to $614,200.18.
About AmerisourceBergen Corp. (NYSE:ABC)
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company's Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.
Recent Trading Activity for AmerisourceBergen Corp. (NYSE:ABC)
Shares of AmerisourceBergen Corp. closed the previous trading session at 90,50 0,00 0,00 % with 90.87 shares trading hands.
